Skip to corpus content
HIMR Public Corpustimestamped source index

Recording summary · September 2023

Why New Investors Lose Money - AVOID These mistakes in the Stock Market

AI-generated reading aids, not verified accounts.

These summaries describe what appears in the transcripts. A speaker’s claims are not established facts, and transcription or speaker-label errors can carry through. Check the linked transcripts and original recordings for context.

Months and years group recording metadata—not necessarily when an event happened. Undated recordings remain separate.

Read this recording’s transcript →

Overview

Daniel incurred substantial trading losses in penny stocks such as Bionano Genomics and Microvision after entering the stock market during the enthusiastic 2020 surge.

Herd mentality, greed, and fear of missing out drive investors to purchase overhyped stocks near peaks and panic sell near market bottoms, leading to severe financial losses.

Sustained profitability requires thorough research, caution at market peaks, profit taking during surges, and buying sound businesses during market declines rather than gambling on unviable meme stocks.

Themes

Personal trading experiences and financial losses in penny stocks such as Bionano Genomics and Microvision.

Psychological cycles of investing, including fear of missing out, greed, overconfidence, and panic selling.

Investment strategies regarding market timing, fundamental research versus meme stocks, and counteracting herd behavior.

Developments

Daniel entered the stock market in 2020 amid market enthusiasm, allocating life savings into penny stocks.

Daniel purchased shares of Bionano Genomics near its peak and sold after a steep drop, losing roughly 60% of the invested capital.

Daniel bought shares of Microvision and subsequently exited the position at an approximate 40% loss.

Meme stock prices experienced heavy market sell-offs around spring 2021 following the GameStop and AMC trading surges.

Uncertainties & gaps

The exact entry and exit purchase prices and precise loss percentages for the Bionano Genomics and Microvision positions are recounted as approximations.

Release summaries_41e8738ae15a49a906b67f18 · · Methodology